Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year โ€“ provided drug makers find innovativeย treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissionsย increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the reportย said.

Related Posts

on

Industry giants have been accused of โ€˜enriching shareholdersโ€™ while โ€˜farmers and consumers pay the priceโ€™.

Industry giants have been accused of โ€˜enriching shareholdersโ€™ while โ€˜farmers and consumers pay the priceโ€™.
on

Nigel Farageโ€™s anti-climate party has received two thirds of its income from oil investors.

Nigel Farageโ€™s anti-climate party has received two thirds of its income from oil investors.
on

You might not have heard of them, but a new analysis shows these ad execs have overseen $1.5 billion worth of fossil fuel ads in the U.S. since the Paris Agreement.

You might not have heard of them, but a new analysis shows these ad execs have overseen $1.5 billion worth of fossil fuel ads in the U.S. since the Paris Agreement.
on

DeSmog analysis reveals London-based WPP linked to twiceย as much oil advertising as American rivalsย despite its internal climate policy.

DeSmog analysis reveals London-based WPP linked to twiceย as much oil advertising as American rivalsย despite its internal climate policy.